These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26962017)

  • 1. M011L-deficient oncolytic myxoma virus induces apoptosis in brain tumor-initiating cells and enhances survival in a novel immunocompetent mouse model of glioblastoma.
    Pisklakova A; McKenzie B; Zemp F; Lun X; Kenchappa RS; Etame AB; Rahman MM; Reilly K; Pilon-Thomas S; McFadden G; Kurz E; Forsyth PA
    Neuro Oncol; 2016 Aug; 18(8):1088-1098. PubMed ID: 26962017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating brain tumor-initiating cells using a combination of myxoma virus and rapamycin.
    Zemp FJ; Lun X; McKenzie BA; Zhou H; Maxwell L; Sun B; Kelly JJ; Stechishin O; Luchman A; Weiss S; Cairncross JG; Hamilton MG; Rabinovich BA; Rahman MM; Mohamed MR; Smallwood S; Senger DL; Bell J; McFadden G; Forsyth PA
    Neuro Oncol; 2013 Jul; 15(7):904-20. PubMed ID: 23585629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cells.
    McKenzie BA; Zemp FJ; Pisklakova A; Narendran A; McFadden G; Lun X; Kenchappa RS; Kurz EU; Forsyth PA
    Neuro Oncol; 2015 Aug; 17(8):1086-94. PubMed ID: 25605818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myxoma virus infection promotes NK lysis of malignant gliomas in vitro and in vivo.
    Ogbomo H; Zemp FJ; Lun X; Zhang J; Stack D; Rahman MM; McFadden G; Mody CH; Forsyth PA
    PLoS One; 2013; 8(6):e66825. PubMed ID: 23762498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular factors promoting resistance to effective treatment of glioma with oncolytic myxoma virus.
    Zemp FJ; McKenzie BA; Lun X; Reilly KM; McFadden G; Yong VW; Forsyth PA
    Cancer Res; 2014 Dec; 74(24):7260-73. PubMed ID: 25336188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to oncolytic myxoma virus therapy in nf1(-/-)/trp53(-/-) syngeneic mouse glioma models is independent of anti-viral type-I interferon.
    Zemp FJ; McKenzie BA; Lun X; Maxwell L; Reilly KM; McFadden G; Yong VW; Forsyth PA
    PLoS One; 2013; 8(6):e65801. PubMed ID: 23762429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myxoma virus virotherapy for glioma in immunocompetent animal models: optimizing administration routes and synergy with rapamycin.
    Lun X; Alain T; Zemp FJ; Zhou H; Rahman MM; Hamilton MG; McFadden G; Bell J; Senger DL; Forsyth PA
    Cancer Res; 2010 Jan; 70(2):598-608. PubMed ID: 20068158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myxoma virus expressing a fusion protein of interleukin-15 (IL15) and IL15 receptor alpha has enhanced antitumor activity.
    Tosic V; Thomas DL; Kranz DM; Liu J; McFadden G; Shisler JL; MacNeill AL; Roy EJ
    PLoS One; 2014; 9(10):e109801. PubMed ID: 25329832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic Delivery of mLIGHT-Armed Myxoma Virus Is Therapeutic for Later-Stage Syngeneic Murine Lung Metastatic Osteosarcoma.
    Christie JD; Appel N; Zhang L; Lowe K; Kilbourne J; Daggett-Vondras J; Elliott N; Lucas AR; Blattman JN; Rahman MM; McFadden G
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo.
    Weng M; Gong W; Ma M; Chu B; Qin Y; Zhang M; Lun X; McFadden G; Forsyth P; Yang Y; Quan Z
    Mol Cancer; 2014 Apr; 13():82. PubMed ID: 24725816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of host range mutants of myxoma virus with altered oncolytic potential in human glioma cells.
    Barrett JW; Alston LR; Wang F; Stanford MM; Gilbert PA; Gao X; Jimenez J; Villeneuve D; Forsyth P; McFadden G
    J Neurovirol; 2007 Dec; 13(6):549-60. PubMed ID: 18097886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
    Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
    Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myxoma virus expressing interleukin-15 fails to cause lethal myxomatosis in European rabbits.
    Liu J; Wennier S; Reinhard M; Roy E; MacNeill A; McFadden G
    J Virol; 2009 Jun; 83(11):5933-8. PubMed ID: 19279088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex Vivo Oncolytic Virotherapy with Myxoma Virus Arms Multiple Allogeneic Bone Marrow Transplant Leukocytes to Enhance Graft versus Tumor.
    Lilly CL; Villa NY; Lemos de Matos A; Ali HM; Dhillon JS; Hofland T; Rahman MM; Chan W; Bogen B; Cogle C; McFadden G
    Mol Ther Oncolytics; 2017 Mar; 4():31-40. PubMed ID: 28345022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological evaluation of intratumoral myxoma virus treatment in an immunocompetent mouse model of melanoma.
    Doty RA; Liu J; McFadden G; Roy EJ; MacNeill AL
    Oncolytic Virother; 2013 Jan; 2():1-17. PubMed ID: 25866742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myxoma virus oncolytic efficiency can be enhanced through chemical or genetic disruption of the actin cytoskeleton.
    Irwin CR; Favis NA; Agopsowicz KC; Hitt MM; Evans DH
    PLoS One; 2013; 8(12):e84134. PubMed ID: 24391902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Myxoma Virus Expressing Walleye Dermal Sarcoma Virus orfC Is Attenuated in Rabbits.
    Ashton LV; Quackenbush SL; Castle J; Wilson G; McCoy J; Jordan M; MacNeill AL
    Viruses; 2020 May; 12(5):. PubMed ID: 32397134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear Export Inhibitor Selinexor Enhances Oncolytic Myxoma Virus Therapy against Cancer.
    Rahman MM; van Oosterom F; Enow JA; Hossain M; Gutierrez-Jensen AD; Cashen M; Everts A; Lowe K; Kilbourne J; Daggett-Vondras J; Karr TL; McFadden G
    Cancer Res Commun; 2023 Jun; 3(6):952-968. PubMed ID: 37377603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis-inducing effect of myxoma virus on human neuroglioma cell lines.
    Zhang QS; Zhang M; Huang XJ; Liu XJ; Li WP
    Exp Ther Med; 2017 Jul; 14(1):344-348. PubMed ID: 28672936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic delivery of TNF-armed myxoma virus plus immune checkpoint inhibitor eliminates lung metastatic mouse osteosarcoma.
    Christie JD; Appel N; Canter H; Achi JG; Elliott NM; de Matos AL; Franco L; Kilbourne J; Lowe K; Rahman MM; Villa NY; Carmen J; Luna E; Blattman J; McFadden G
    Mol Ther Oncolytics; 2021 Sep; 22():539-554. PubMed ID: 34553039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.